Johnson & Johnson (LON:0R34)

Market Cap	304.23B
Revenue (ttm)	66.08B
Net Income (ttm)	16.52B
Shares Out	n/a
EPS (ttm)	6.81
PE Ratio	18.41
Forward PE	15.31
Dividend	3.87 (2.33%)
Ex-Dividend Date	May 27, 2025

Volume	3,343
Average Volume	37,830
Open	164.86
Previous Close	165.16
Day's Range	163.00 - 166.59
52-Week Range	139.94 - 169.99
Beta	n/a
RSI	60.14
Earnings Date	Jul 16, 2025

About United States Steel

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Pharmaceutical Preparations
• Founded: 1886
• Employees: 138,100
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0R34

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.